KR940009154A - 약리학적 활성을 갖는 테트랄론, 이를 함유하는 조성물 및 이의 제조방법 - Google Patents

약리학적 활성을 갖는 테트랄론, 이를 함유하는 조성물 및 이의 제조방법 Download PDF

Info

Publication number
KR940009154A
KR940009154A KR1019930020516A KR930020516A KR940009154A KR 940009154 A KR940009154 A KR 940009154A KR 1019930020516 A KR1019930020516 A KR 1019930020516A KR 930020516 A KR930020516 A KR 930020516A KR 940009154 A KR940009154 A KR 940009154A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
solvent
pyridyl
Prior art date
Application number
KR1019930020516A
Other languages
English (en)
Korean (ko)
Inventor
알만사 까르멘
곤잘레스 꼰쎄프시옹
까르멘 토레스 마
까르세예르 엘레나
바르뜨롤리 하비에르
Original Assignee
후안 우리아치 마샬
호따. 우리아치 에 씨아. 에세. 아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후안 우리아치 마샬, 호따. 우리아치 에 씨아. 에세. 아. filed Critical 후안 우리아치 마샬
Publication of KR940009154A publication Critical patent/KR940009154A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
KR1019930020516A 1992-10-19 1993-10-05 약리학적 활성을 갖는 테트랄론, 이를 함유하는 조성물 및 이의 제조방법 KR940009154A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES09202203A ES2064228B1 (es) 1992-10-19 1992-10-19 Nuevas tetralonas con actividad farmacologica, composiciones que las contienen y procedimiento para su preparacion.
ES9202203 1992-10-19

Publications (1)

Publication Number Publication Date
KR940009154A true KR940009154A (ko) 1994-05-20

Family

ID=8278646

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930020516A KR940009154A (ko) 1992-10-19 1993-10-05 약리학적 활성을 갖는 테트랄론, 이를 함유하는 조성물 및 이의 제조방법

Country Status (7)

Country Link
US (1) US5356915A (de)
EP (1) EP0600147A1 (de)
JP (1) JPH07291932A (de)
KR (1) KR940009154A (de)
CA (1) CA2097045A1 (de)
ES (1) ES2064228B1 (de)
MX (1) MX9302429A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
CN100549004C (zh) * 2003-10-01 2009-10-14 阿得罗公司 螺环杂环衍生物及其应用方法
US20060029530A1 (en) * 2004-08-09 2006-02-09 Gloria Gremillion Perfect tooth brush sterilize
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
AU2007294968A1 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of N-containing spirocompounds for the enhancement of cognitive function

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1493848A (en) * 1975-07-24 1977-11-30 Beecham Group Ltd Aryltetralins
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
EP0489300A3 (en) * 1990-12-05 1993-03-17 J. Uriach & Cia. S.A. New tetralones with pharmacological activity
CA2074864A1 (en) * 1991-07-30 1993-01-31 Carmen Almansa Tetralones with pharmacological activity

Also Published As

Publication number Publication date
ES2064228A1 (es) 1995-01-16
US5356915A (en) 1994-10-18
ES2064228B1 (es) 1995-09-01
JPH07291932A (ja) 1995-11-07
CA2097045A1 (en) 1994-04-20
EP0600147A1 (de) 1994-06-08
MX9302429A (es) 1994-04-29

Similar Documents

Publication Publication Date Title
RU2220144C2 (ru) Новые тетрациклические аналоги камптотецинов, способы их получения, промежуточные соединения и фармацевтическая композиция на их основе
EP0689535B1 (de) Benzimidazole derivate
EP1073637B1 (de) 3-(amino- oder aminoalkyl)pyridinon-derivate und ihre anwendung bei der behandlung von mit hiv zusammenhängenden krankheiten
EP2385039A1 (de) 2-Iminoisoindolinon-Derivate als Antagonisten des Thrombin-Rezeptors
DD264432A5 (de) Verfahren zur herstellung von durch heterozyklen alpha-substituierten tolunitrilen
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
ES8703846A1 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
DE69120100D1 (de) Annelierte Thiophen-Derivate, ihre Herstellung und Verwendung
HU180945B (en) Process for preparing pyrimidones
ES2170732A1 (es) Procedimiento para preparar citalopram purificado
EP0915094A4 (de) Morphinanderivate und ihre medizinische Anwendung
KR940009154A (ko) 약리학적 활성을 갖는 테트랄론, 이를 함유하는 조성물 및 이의 제조방법
HUT63143A (en) Process for producing diamine derivatives and pharmaceutical compositions comprising such active ingredient
WO2001012169A3 (en) Method of cancer treatment
CA1331991C (en) Imidazo/2,1-b/benzothiazoles useful in the treatment of memory disorders and/or irritable conditions
WO2001085720A1 (en) Novel anti-infectives
JPS6233161A (ja) １，５−ベンゾジアゼピン化合物
US4650797A (en) Substituted 1,5-benzodiazepine compounds
EP2340249B1 (de) Polyheteroarylderivate zur behandlung von krebs
Togo et al. Cyclic amination onto aromatic ring of sulfonamides with (diacetoxyiodo) arenes: Effect of sulfonyl group
AR005120A1 (es) Derivados 4-(1h-benzimidazol-2-il) [1,4]diazepanos substituidos utiles para el tratamiento de enfermedades alergicas, composicion farmaceutica y usos en la fabricacion de medicamentos.
ES8600244A1 (es) Procedimiento de preparacion de nuevos derivados piridinicos y de sus sales de adicion acidas y cuaternarias
Arndt et al. Stereoselective Synthesis of trans‐threo‐trans‐Oligopyrrolidines: Potential Agents for RNA Cleavage
US3580909A (en) 4-styrylpyridines

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid